Q/C Technologies, Inc. Gain (Loss) on Sale of Derivatives
Q/C Technologies, Inc. (QCLS) reported Gain (Loss) on Sale of Derivatives of -$1.06 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2025-11-19
- Q/C Technologies, Inc. gain (loss) on sale of derivatives for the quarter ending 2025-09-30 was -$1.06M.
- Q/C Technologies, Inc. gain (loss) on sale of derivatives for the quarter ending 2025-06-30 was $19.00K.
- Q/C Technologies, Inc. gain (loss) on sale of derivatives for the quarter ending 2025-03-31 was $1.28M, a 2004.92% increase year-over-year.
- Q/C Technologies, Inc. gain (loss) on sale of derivatives for the quarter ending 2024-09-30 was -$356.00K.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month |
|---|---|---|---|
| 2025-09-30 | -$1.06M 10-Q · filed 2025-11-19 | -$1.04M derived: sum of 2 quarters · filed 2025-11-19 | $244.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $19.00K 10-Q · filed 2025-08-19 | $1.30M 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $1.28M 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | -$356.00K 10-Q · filed 2025-11-19 | -$428.00K derived: sum of 2 quarters · filed 2025-11-19 | -$367.00K 10-Q · filed 2025-11-19 |
| 2024-06-30 | -$72.00K 10-Q · filed 2025-08-19 | -$11.00K 10-Q · filed 2025-08-19 | |
| 2024-03-31 | $61.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |